Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Goodsaid

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Discovery|April 5, 2012
Challenges of biomarkers in drug discovery and developmentFederico Goodsaid
The AAPS Journal|April 6, 2007
Biomarker qualification pilot process at the US Food and Drug AdministrationFederico Goodsaid, Felix Frueh
Pharmacogenomics|August 5, 2006
Process map proposal for the validation of genomic biomarkersFederico Goodsaid, Felix Frueh
Environmental and Molecular Mutagenesis|June 15, 2007
Implementing the U.S. FDA guidance on pharmacogenomic data submissionsFederico Goodsaid, Felix W Frueh
Experimental Biology and Medicine (Maywood, N.J.)|November 8, 2017
Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practiceWilliam B Mattes, Federico Goodsaid
Proteomics. Clinical Applications|December 8, 2010
Grand rounds in proteomics at the FDA white oak, silver spring, MD, USA, april 3, 2007Federico Goodsaid, Julia Elisabeth Bandow, Harald Mischak
Biomarkers in Medicine|April 22, 2010
Molecular biomarkers: a US FDA effortHuixiao Hong, Federico Goodsaid, Leming Shi, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Qualifying biomarkers for use in drug development: a US Food and Drug Administration overviewJanet Woodcock, Shaavhree Buckman, Federico Goodsaid, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Application of pharmacogenomics in clinical pharmacologyShiew-Mei Huang, Federico Goodsaid, Atiqur Rahman, et al.
Pharmacogenomics|December 24, 2008
Drug-diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics WorkshopLois Hinman, Brian Spear, Zenta Tsuchihashi, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Discovery|April 5, 2012
Challenges of biomarkers in drug discovery and developmentFederico Goodsaid
The AAPS Journal|April 6, 2007
Biomarker qualification pilot process at the US Food and Drug AdministrationFederico Goodsaid, Felix Frueh
Pharmacogenomics|August 5, 2006
Process map proposal for the validation of genomic biomarkersFederico Goodsaid, Felix Frueh
Environmental and Molecular Mutagenesis|June 15, 2007
Implementing the U.S. FDA guidance on pharmacogenomic data submissionsFederico Goodsaid, Felix W Frueh
Experimental Biology and Medicine (Maywood, N.J.)|November 8, 2017
Regulatory landscapes for biomarkers and diagnostic tests: Qualification, approval, and role in clinical practiceWilliam B Mattes, Federico Goodsaid
Proteomics. Clinical Applications|December 8, 2010
Grand rounds in proteomics at the FDA white oak, silver spring, MD, USA, april 3, 2007Federico Goodsaid, Julia Elisabeth Bandow, Harald Mischak
Biomarkers in Medicine|April 22, 2010
Molecular biomarkers: a US FDA effortHuixiao Hong, Federico Goodsaid, Leming Shi, et al.
Expert Opinion on Medical Diagnostics|March 15, 2013
Qualifying biomarkers for use in drug development: a US Food and Drug Administration overviewJanet Woodcock, Shaavhree Buckman, Federico Goodsaid, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Application of pharmacogenomics in clinical pharmacologyShiew-Mei Huang, Federico Goodsaid, Atiqur Rahman, et al.
Pharmacogenomics|December 24, 2008
Drug-diagnostic codevelopment strategies: FDA and industry dialog at the 4th FDA/DIA/PhRMA/PWG/BIO Pharmacogenomics WorkshopLois Hinman, Brian Spear, Zenta Tsuchihashi, et al.
Pageof 3